D'ONGHIA, MARIANGELA
 Distribuzione geografica
Continente #
NA - Nord America 671
EU - Europa 104
AS - Asia 89
Continente sconosciuto - Info sul continente non disponibili 3
Totale 867
Nazione #
US - Stati Uniti d'America 665
CN - Cina 58
SE - Svezia 35
SG - Singapore 23
IT - Italia 16
DE - Germania 13
FI - Finlandia 11
BE - Belgio 8
GB - Regno Unito 8
RU - Federazione Russa 8
CA - Canada 6
VN - Vietnam 4
EU - Europa 2
HK - Hong Kong 2
ID - Indonesia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
FR - Francia 1
IE - Irlanda 1
LT - Lituania 1
RO - Romania 1
UA - Ucraina 1
Totale 867
Città #
Fairfield 120
Woodbridge 91
Houston 67
Chandler 62
Ashburn 50
Seattle 47
Cambridge 36
Nyköping 26
Beijing 25
Ann Arbor 24
Wilmington 24
Singapore 20
Jacksonville 10
Roxbury 10
Munich 9
Brussels 8
Lawrence 8
Nanjing 7
Bari 6
Brooklyn 6
Des Moines 6
Norwalk 6
Princeton 6
Toronto 6
Shenyang 5
Dong Ket 4
Inglewood 4
Redwood City 4
San Diego 4
Dearborn 3
Hebei 3
Helsinki 3
London 3
Tianjin 3
Boardman 2
Frankfurt am Main 2
Hong Kong 2
Jakarta 2
Jesi 2
Jiaxing 2
Los Angeles 2
Phoenix 2
Santa Clara 2
Taranto 2
Brierley Hill 1
Chengdu 1
Chicago 1
Dalian 1
Dublin 1
Guangzhou 1
Guiyang 1
Hanover 1
Hefei 1
Irvine 1
Jinan 1
Kansas City 1
Leninsk-kuznetskiy 1
Lviv 1
Marseille 1
New Bedfont 1
Ningbo 1
Quzhou 1
Santa Marinella 1
Shanghai 1
Trani 1
Wuhan 1
Totale 758
Nome #
Long-term cardiac safety and tolerability of fingolimod in multiple sclerosis: A postmarketing study 134
The Cost of Patients With Relapsing-Remitting Multiple Sclerosis Who Develop Neutralizing Antibodies While Treated With Interferon Beta 126
The cost of relapsing-remitting multiple sclerosis patients who develop neutralizing antibodies during interferon beta therapy 111
Lymphocyte subsets as biomarkers of therapeutic response in Fingolimod treated Relapsing Multiple Sclerosis patients 108
Lymphocyte count and body mass index as biomarkers of early treatment response in a multiple sclerosis dimethyl fumarate-treated cohort 97
Cerebrospinal fluid neurofilament light levels mark grey matter volume in clinically isolated syndrome suggestive of multiple sclerosis 96
Long-Term Data of Efficacy, Safety, and Tolerability in a Real-Life Setting of THC/CBD Oromucosal Spray-Treated Multiple Sclerosis Patients 95
The role of neutralizing antibodies to interferon-β as a biomarker of persistent MRI activity in multiple sclerosis: a 7-year observational study 75
null 65
null 21
Totale 928
Categoria #
all - tutte 3.784
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.784


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020154 0 0 0 0 0 0 24 33 29 26 35 7
2020/2021151 16 10 12 10 12 12 21 13 8 18 9 10
2021/202292 6 6 0 2 5 10 4 5 8 11 16 19
2022/2023146 22 22 8 20 13 13 0 18 21 1 3 5
2023/202428 4 7 2 5 3 1 0 2 0 0 0 4
2024/202570 12 2 21 12 7 14 2 0 0 0 0 0
Totale 928